leadf
logo-loader
viewFutura Medical PLC

Futura Medical highlights "huge interest" for erectile dysfunction gel based on Ipsos research

James Barder, chief executive officer at Futura Medical (LON:FUM) discusses the Ipsos findings that show its treatment for erectile dysfunction has the potential to be a US$1bn drug.

Quick facts: Futura Medical PLC

Price: 15.5 GBX

AIM:FUM
Market: AIM
Market Cap: £38.07 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Futura Medical announce regulatory and commercial progress on erectile...

Futura Medical PLC's (LON:FUM) James Barder talks to Proactive London's Katie Pilbeam about the announcement made today on the regulatory progress in the US. Barder also hints upon significant commercial interest for its erectile dysfunction gel with talks ongoing with a growing number of...

on 22/10/20

2 min read